Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfar S Azmi

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Cancer Letters|October 4, 2016
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasoneIrfana Muqbil, Amro Aboukameel, Sivan Elloul, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 functionAsfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.
International Journal of Molecular Sciences|July 2, 2021
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer CellsMd Hafiz Uddin, Yiwei Li, Husain Yar Khan, et al.
The Journal of Biological Chemistry|April 11, 2014
Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1Bin Bao, Asfar S Azmi, Amro Aboukameel, et al.
BMC Systems Biology|September 6, 2013
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25Asfar S Azmi, Aliccia Bollig-Fischer, Bin Bao, et al.
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Journal of Cellular Physiology|June 17, 2011
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancerUzma Shamim, Sarmad Hanif, Abdulmajeed Albanyan, et al.
Targeted Oncology|March 13, 2026
First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid MalignanciesAlbiruni Razak, Amit Mahipal, Jennifer R Diamond, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
International Journal of Molecular Sciences|January 8, 2020
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy ResistanceHusain Yar Khan, James Ge, Misako Nagasaka, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Cancer Letters|October 4, 2016
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasoneIrfana Muqbil, Amro Aboukameel, Sivan Elloul, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 functionAsfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.
International Journal of Molecular Sciences|July 2, 2021
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer CellsMd Hafiz Uddin, Yiwei Li, Husain Yar Khan, et al.
The Journal of Biological Chemistry|April 11, 2014
Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1Bin Bao, Asfar S Azmi, Amro Aboukameel, et al.
BMC Systems Biology|September 6, 2013
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25Asfar S Azmi, Aliccia Bollig-Fischer, Bin Bao, et al.
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Journal of Cellular Physiology|June 17, 2011
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancerUzma Shamim, Sarmad Hanif, Abdulmajeed Albanyan, et al.
Targeted Oncology|March 13, 2026
First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid MalignanciesAlbiruni Razak, Amit Mahipal, Jennifer R Diamond, et al.
International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.
International Journal of Molecular Sciences|January 8, 2020
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy ResistanceHusain Yar Khan, James Ge, Misako Nagasaka, et al.
Pageof 16